Although the initial identification of lost Grb10 expression was made in our Nf1 mutant-based mouse model of cancer, studies in human tumor cell lines as well as malignant cells generated from Nf1 wildtype backgrounds suggest that Grb10 loss may have tumor-promoting consequences in other oncogenic contexts. The gene discussed is NF1; the disease is neoplasm.